AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published March 11, 2009

American Journal of Neuroradiology 2009;30:649.

This Article
Free to Access This article has been Unlocked
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1486v1
30/4/649    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nogueira, R.G.
Right arrow Articles by Hirsch, J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nogueira, R.G.
Right arrow Articles by Hirsch, J.A.

REVIEW ARTICLE

Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data

R.G. Nogueira, L.H. Schwamm and J.A. Hirsch

From the Endovascular Neurosurgery/Interventional Neuroradiology Section (R.G.N., J.A.H.), Departments of Radiology and Neurosurgery, and Neurocritical Care and Vascular Neurology Section (R.G.N., L.H.S.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Please address correspondence to: Raul G. Nogueira, MD, Department of Interventional Neuroradiology and Endovascular Neurosurgery, Massachusetts General Hospital, 55 Fruit St, GRB-2-241, Boston, MA, 02114; e-mail: rnogueira{at}partners.org

SUMMARY: Despite years of research and pioneering clinical work, stroke remains a massive public health concern. Since 1996, we have lived in the era of US Food and Drug Administration–approved intravenous (IV) recombinant tissue plasminogen activator (rtPA). This treatment, despite its promise, continues to exhibit its limitations. Endovascular therapy has several theoretic advantages over IV rtPA, including site specificity, longer treatment windows, and higher recanalization rates. In this article, we will review the various pharmacologic strategies for acute stroke treatment, providing both a historic context and the state of the art. The drugs will be classified on the basis of their theoretic rationale for therapy. Next, we will review the various devices and strategies for mechanical revascularization with an aim toward comprehensiveness. These range from wire disruption of thrombus to preclinical trials for novel mechanical solutions. This first installment of this 2-part series will end with an analysis of retrograde reperfusion techniques.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
R.G. Nogueira, A.J. Yoo, F.S. Buonanno, and J.A. Hirsch
Endovascular Approaches to Acute Stroke, Part 2: A Comprehensive Review of Studies and Trials
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 859 - 875.
[Abstract] [Full Text] [PDF]